599 related articles for article (PubMed ID: 19628668)
1. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
[TBL] [Abstract][Full Text] [Related]
2. Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/β-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria.
Jiang L; Xu L; Song Y; Li J; Mao J; Zhao AZ; He W; Yang J; Dai C
J Biol Chem; 2013 Aug; 288(32):23368-79. PubMed ID: 23803607
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria.
Zhou L; Chen X; Lu M; Wu Q; Yuan Q; Hu C; Miao J; Zhang Y; Li H; Hou FF; Nie J; Liu Y
Kidney Int; 2019 Apr; 95(4):830-845. PubMed ID: 30770219
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling.
Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y
Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212
[No Abstract] [Full Text] [Related]
5. Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.
Zhou D; Wang Y; Gui Y; Fu H; Zhou S; Wang Y; Bastacky SI; Stolz DB; Liu Y
Kidney Int; 2022 Jul; 102(1):96-107. PubMed ID: 35341792
[TBL] [Abstract][Full Text] [Related]
6. Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria.
Wang D; Dai C; Li Y; Liu Y
Kidney Int; 2011 Dec; 80(11):1159-1169. PubMed ID: 21832980
[TBL] [Abstract][Full Text] [Related]
7. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
8. Metadherin orchestrates PKA and PKM2 to activate β-catenin signaling in podocytes during proteinuric chronic kidney disease.
Chen X; Xiao J; Tao D; Liang Y; Chen S; Shen L; Li S; Zheng Z; Zeng Y; Luo C; Peng F; Long H
Transl Res; 2024 Apr; 266():68-83. PubMed ID: 37995969
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival.
Kato H; Gruenwald A; Suh JH; Miner JH; Barisoni-Thomas L; Taketo MM; Faul C; Millar SE; Holzman LB; Susztak K
J Biol Chem; 2011 Jul; 286(29):26003-15. PubMed ID: 21613219
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
[TBL] [Abstract][Full Text] [Related]
11. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
He W; Kang YS; Dai C; Liu Y
J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro.
Jing Z; Wei-jie Y; Yi-Feng ZG
Cell Signal; 2015 Sep; 27(9):1772-80. PubMed ID: 26049137
[TBL] [Abstract][Full Text] [Related]
13. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
Li Z; Xu J; Xu P; Liu S; Yang Z
Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354
[TBL] [Abstract][Full Text] [Related]
15. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
16. β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.
Wang Y; Li H; Song SP
Med Sci Monit; 2018 Mar; 24():1724-1732. PubMed ID: 29572435
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin.
Hu M; Wang R; Li X; Fan M; Lin J; Zhen J; Chen L; Lv Z
J Cell Mol Med; 2017 Nov; 21(11):2732-2747. PubMed ID: 28444861
[TBL] [Abstract][Full Text] [Related]
19. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
20. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]